CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 33,500 | ||
| 2026-03-04 | Thompson Tommy G Director | Option exercise | +2,000 | $101.80 | $204K | 10,480 |
| 2026-03-04 | Thompson Tommy G Director | Sale | −2,000 | $489.42 | $979K | 8,480 |
| 2026-03-04 | Thompson Tommy G Director | Option exercise · Stock Option | −2,000 | 2,000 | ||
| 2026-03-04 | CAUSEY CHRISTOPHER Director | Option exercise 10b5-1 | +20 | $119.76 | $2K | 4,210 |
| 2026-03-04 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −20 | $490.17 | $10K | 4,190 |
| 2026-03-04 | CAUSEY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −20 | 6,300 | ||
| 2026-03-04 | KURZWEIL RAY Director | Option exercise | +4,910 | $101.80 | $500K | 17,580 |
| 2026-03-04 | KURZWEIL RAY Director | Sale | −4,910 | $489.02 | $2.4M | 12,670 |
| 2026-03-04 | KURZWEIL RAY Director | Option exercise · Stock Option | −4,910 | 0 | ||
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | +9,500 | $146.03 | $1.4M | 9,630 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −399 | $486.42 | $194K | 9,231 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −926 | $487.55 | $451K | 8,305 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,429 | $488.63 | $1.2M | 5,876 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,290 | $489.68 | $1.1M | 3,586 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,808 | $490.52 | $887K | 1,778 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −485 | $491.33 | $238K | 1,293 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −243 | $492.44 | $120K | 1,050 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −185 | $493.40 | $91K | 865 |
| 2026-03-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −215 | $494.74 | $106K | 650 |
Page 154 of 171 · 3,408 trades